Full-time Lecturer: Educational Administration/Management x2 (Gweru Campus)

Full Time Lecturer: Computer Science

Students on Attachment: Accounting/Finance (Harare)

Human Resources Student Intern (Harare)

Gender, Youth and Social Inclusion Officer (Harare)

Field Officer-Livelihoods x3 (Harare)

Project Accountant (Bulawayo)

HIV Prevention and ASRH Officer x2 (Harare)

Sales Graduate TraineE (Harare)

Site Security Guards Supervisor (Harare)

Risk Officer (Harare)

Branch Manager (Chiredzi)

Legal and Compliance Officer (Harare)

Class Two (2) Truck Drivers x54

Dispensary Assistant (Harare)

Account Student for Attachment (Harare)

Senior Loans And Administration Officer

Loans Officer (Harare)

Welder (Harare)

School Nurse (Harare)

Field Officer (Kariba)

Driver (Harare)

Human Resources & Finance Assistant (Gwanda)

Cook (Gwanda)

Student Attachees: Retail (Bulawayo)

Student Attachees: ICT

Community Development Worker (Harare)

Infrastructure Specialist (Harare)

Finance Intern/ Attache` (Harare)

TOPP Trainee (Harare)

Step User (Chihota)

Disability Inclusion Officer (Mudzi)

Lecturers

Executive Director

Finance and Human Resources Manager

Software Engineer

Network Administrator

Workshop Operative

TFCA Programme Officer (Grade: D1)

Actuarial Analyst

Creative Design Officer

Marketing and Communications Officer (Harare)

Howo Drivers (Hwange)

Communications Intern (Harare)

Control Technician (Harare)

ICT Enterprise Solutions Consultants (Harare)

Sales Consultant (Harare)

Procurement and Logistics Officer (Harare)

Entrepreneurship Skills Coordinator (Harare)

Human Resource Officer (Mutare)

Finance Officer (Mutare)

Education, Parenting, and In-School Officers x3

DREAMS Data Collation Clerks x32

DREAMS District Mentor (Seke)

Young KP Field Officer (Seke)

DREAMS Program Nurses x10

Facility Priority Services (PMTCT/Paeds) Focal Person x50

No Means No Lead Trainers x12

Families Matter Program (FMP) Facilitators x16 (Nkayi)

Administrative Trainees x5 (Lupane)

Sport Development Officers (Harare)

Co-ordinator for Director Commercial (Harare)

Public and Media Relations Officer (Harare)

Business Development Officer (Harare)

Legal Officer (Harare)

Scholarship Opportunities

Part-Time Welder/ Fabricator (Harare)

Part-Time Repairs/ Faults Technicians (Harare)

Part-Time Solar Systems Installation Technician (Harare)

Part-Time Bookkeeper (Harare)

Deputy Librarian

ICT Technician (Bulawayo)

Library Assistants x2 (Harare)

Security Guards x3 (Harare)

Digital Campaign Officer (Harare)

Risk Analyst (Harare)

Furniture Designer (Bulawayo)

3 Wheeler Van Salesman (Bulawayo)

Regional Finance And Administration Assistant x4 (Harare, Mutare, Bulawayo & Gweru)

Homebased RGN (Harare)

DHIS2 Specialist (Tsholotsho)

Database Modeller (Bubi)

Systems Support Specialist (Lupane)

Systems Engineer

Branch Managers (Kadoma & Shurugwi)

Products & Research Officer

Livestock Technician

Lecturer/ Senior Lecturer/ Associate Professor/ Professor: Soil Biology And Fertility

Lecturer/ Senior Lecturer/ Associate Professor/ Professor In Ndebele

Sports Director

Catering And Accommodation Manager

Internal Auditor

Chief Security Officer

Director, Information And Communication Technology

Assistant Shelter Coordinator (Harare)

Medical Laboratory Scientist (Bindura)

SHE Officer (Shurugwi)

Receptionist (Harare)

Driver: Confucius Institute

The Medicines Control Authority of Zimbabwe (MCAZ) has ordered healthcare professionals to advise patients to stop taking pholcodine-containing medicines.
Pholcodine is an opioid medicine that is used in adults and children for the treatment of non-productive (dry) cough and, in combination with other active substances, for the treatment of symptoms of cold and flu.
In Zimbabwe, pholcodine-containing products are marketed under the brand names Pholtex Plus and Pholtex Forte with the registration numbers 2018/22.2.5/5734 and 99/22.2.1/3624 respectively.
In a recent statement, MCAZ director general Richard Rukwata said:
<blockquote>
MCAZ would like to advise all stakeholders of a significant safety issue with pholcodine-containing medicines.
Available data indicate that the use of pholcodine in the 12 months before general anesthesia with neuromuscular blocking agents (NMBA) such as suxamethonium, and atracurium is a risk factor for developing an anaphylactic reaction upon administration of the NMBA.
The Authority would like to draw the attention of all licensed pharmaceutical wholesalers, pharmacies, public and private clinics, and hospitals that they must quarantine the stated products.
… due to the seriousness of the safety risk, all pholcodine-containing products are being withdrawn from the Zimbabwean market.
Health care professionals, advise patients to stop taking pholcodine-containing medicines and consider appropriate alternatives to treat their symptoms.
Check whether patients scheduled to undergo general anesthesia with NMBAs have used pholcodine in the previous 12 months and remain aware of the risk of anaphylactic reactions in those patients.
</blockquote>
The UK government says there is already a known link between pholcodine and an increased risk of the very rare event of a severe allergic reaction (anaphylaxis) to muscle relaxants (neuromuscular blocking agents) that are used during general anaesthesia in surgery.
More: <a href="https://zero.pindula.co.zw/">Pindula News</a>

Pindula News

Zimbabwe Bans Use Of Cough Medicine Containing Pholcodine

The Medicines Control Authority of Zimbabwe (MCAZ) has expressed concern over the increased advertising of medicines on social media platforms such as Facebook, WhatsApp, and Twitter saying it is in violation of the law.
MCAZ said an advertisement according to the Medicines and Allied Substances Control Act (Chapter 15:03) in relation to any medicine, means any written, pictorial, visual, or other descriptive matter or verbal statement or reference.
In a statement, MCAZ said section 65(1)(b) states that no person shall advertise any other medicine without the approval of the authority in writing. It added:
<blockquote>
Any person who contravenes the provisions of these regulations, other than a provision for the contravention of which a penalty is provided by subsection (3) of section 38 or subsection (2a) of section 39 of the Act, shall be guilty of an offence and liable to a fine not exceeding level seven or to imprisonment for a period not exceeding six months or to both such fine and such imprisonment.
</blockquote>
MCAZ said it will work with the Zimbabwe Republic Police (ZRP) to take necessary measures including prosecution, against those illegally advertising medicines on social media.

Advertising Of Medicines On Social Media Worries Medicines Control Authority

Zimbabwe has become the first African country to approve the use of long-acting injectable, Cabotegravir (CAB-LA), a pre-exposure prophylaxis (Prep) dose for HIV prevention.
The Medicines Control Authority of Zimbabwe (MCAZ) on Monday announced the approval of the use of the drug.
According to the World Health Organisation (WHO), “CAB-LA may be offered to people at substantial risk of HIV acquisition as part of comprehensive HIV prevention approaches”.
CAB-LA injections are to be taken every two months and studies have shown that they are highly effective in reducing the risk of HIV acquisition among homosexual men, transgender, and cisgender women.
Community Working Group on Health (CWGH) executive director Itai Rusike applauded the move to approve the use of the drug in Zimbabwe. He said:
<blockquote>
Prep dramatically reduces the risk of HIV acquisition for women as well as men.
We are aware that for more than a decade, WHO has recommended that pregnant and breastfeeding women at risk of HIV should be offered Prep.
The people of Zimbabwe should embrace this new development in order to reduce the risk of HIV infection.
</blockquote>
Development Agenda for Girls and Women in Africa Network representative Nyasha Sithole said “this will contribute to our basket of HIV prevention tools that work for us as girls and women in Zimbabwe”. | <a href="https://www.newsday.co.zw/local-news/article/200002248/zim-pilots-new-hiv-drug">NewsDay</a>

Zimbabwe Becomes First African Country To Approve Use Of New HIV Drug

The Medicines Control Authority of Zimbabwe (MCAZ) has said Superlife Total Care (STC30) has not been registered with the Authority and is therefore illegal.
STC30 is herbal medicine trending on social media and its promoters claim that it cures almost every other disease and condition.
In a statement, MCAZ Acting Director General Richard Rukwata said STC 30 has not been approved for sale in Zimbabwe and members of the public should avoid buying the product.
The Medicines Control Authority of Zimbabwe is the regulator mandated to safeguard the safety of public and animal health. Said Rukwata:
<blockquote>
Superlife Total Care (STC30) and many similar products with their numerous medicinal and health claims make them registrable products.
However, STC30 is currently not registered and not approved for sale in Zimbabwe.
As the Authority we have noted the continued advertising and marketing of STC30 products, especially on social media.
We urge members of the public to desist from buying such products which have not gone through any clinical trials and therefore their safety and efficacy have not been proven. Members of the public are encouraged to buy medicines from registered premises and persons. These lists can be found on the online register found on our <a href="https://onlineservices.mcaz.co.zw/onlineregisterformPersonsRegister.aspx">website</a>.
</blockquote>
Rukwata warned that those marketing and distributing STC30 are breaking the law. He said:
<blockquote>
The continued marketing and advertising of such unregistered “medicinal” products is not only an act of criminality but also puts the lives of the citizens at risk.
As the Authority responsible for protecting public and animal health, MCAZ enforces adherence to standards by manufacturers and distributors and will exercise its statutory mandate against the perpetrators of these criminal acts.
</blockquote>
|<a href="https://healthtimes.co.zw/2022/09/16/herbal-product-stc-30-illegal-in-zimbabwe-mcaz/"> Health Times</a>

MCAZ Says Herbal Product, STC 30 Is Illegal In Zimbabwe

MCAZ Latest News

Latest Jobs